news and events

ClinDatrix provided full service for the successful Phase 3 study of the following contact lens solution for Bausch + Lomb:

Bausch + Lomb Introduces renuĀ® Advanced Formula Multi-Purpose Solution

ClinDatrix provided full service for the Phase 2 and Phase 3 studies leading to the approval of Endari, an orphan drug for sickle cell disease for Emmaus Medical:

FDA approves new treatment for sickle cell disease

 

We look forward to meeting with you in person – at your office or ours, or at an upcoming industry conference.

Events

Feb 21-22, 2018 Outsourcing in Clinical Trials West Coast, Burlingame, CA
Jun 24-28, 2018 DIA, Boston, MA
Sep 12-13, 2018 Outsourcing in Clinical Trials Midwest, Chicago, IL
Sep 26-27, 2018 Outsourcing in Clinical Trials Southern California, La Jolla, CA
Oct 23-24, 2018 Outsourcing in Clinical Trials Canada, Vancouver BC